Prothrombin Complex Concentrate Market – Opportunities, Share, Growth and Competitive Analysis and Forecast 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Projected Valuation Of The Prothrombin Complex Concentrate Market In The Coming Years?
In recent times, the prothrombin complex concentrate market has seen robust growth. It’s projected that the market size will rise from $1.29 billion in 2024 to $1.38 billion in 2025, recording a compound annual growth rate (CAGR) of 6.7%. The historical growth can be credited to an increase in bleeding disorders, more frequent use in counteracting warfarin, heightened awareness around coagulation treatments, an increase in surgical procedures, and a rise in trauma cases.
It is anticipated that the prothrombin complex concentrate market will undergo substantial growth in the forthcoming years, potentially rising to an estimated $1.83 billion by 2029 at a compound annual growth rate (CAGR) of 7.3%. This expected growth in the prediction period is primarily due to the escalating demand for swift coagulation treatments, a heightened frequency of hemophilia and liver diseases, an increase in emergency medicine application rates, the broadening use in cardiac surgeries, and increased health care spending. The forecast period is also expected to observe significant trends such as the use of AI in diagnostics, advances in recombinant coagulation factors, the arrival of next-generation recombinant PCCs, personalized dosing algorithms’ implementation, and progresses in blood plasma product technologies.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23488&type=smp
What Drivers Are Accelerating Expansion Of The Prothrombin Complex Concentrate Market?
The escalating frequency of bleeding disorders is set to drive the expansion of the prothrombin complex concentrate market. Medical conditions that prevent the blood from clotting effectively, resulting in excessive bleeding due to missing or non-functioning clotting factors or platelets, are known as bleeding disorders. These complications are on the rise, mainly due to the growing occurrence of genetic disorders like hemophilia, increased instances of liver disease, widened usage of anticoagulant medicines, and a surge in the number of vitamin K deficiencies. Prothrombin complex concentrate provides an effective treatment for bleeding disorders as it replenishes clotting factors swiftly, which are vital for effective blood coagulation and hemostasis. In a specific case reported by the National Library of Medicine, a medical library based in the U.S., in November 2023, a study was conducted on 10,276 individuals with hemophilia in 87 treatment centers spread over 40 countries in the year 2022. Approximately 49% of these participants had serious hemophilia, 99% were male, and 85% were diagnosed with Hemophilia A. Of this group, 67% of the patients hailed from low to middle-income countries. Thus, the rising frequency of bleeding disorders is catalyzing the expansion of the prothrombin complex concentrate market.
How Is The Global Prothrombin Complex Concentrate Market Broken Down By Segment?
The prothrombin complex concentratemarket covered in this report is segmented –
1) By Product: 3-Factor Prothrombin Complex Concentrates; 4-Factor Prothrombin Complex Concentrates; Other Products
2) By Indication: Haemorrhagic Episodes In Factor IX Deficiency (Haemophilia B); Trauma; Life-Threatening Coagulopathy With Acute Bleeding; Warfarin-Associated Acute, Life-Threatening Bleeding; Non-Warfarin Anticoagulant Reversal With Acute Bleeding
3) By Route Of Administration: Intravenous; Subcutaneous; Intramuscular
4) By End-Use: Hospital And Ambulatory Surgical Centers; Specialty Clinics; Other End Users
Subsegments:
1) By Type: Low-Dose 3-Factor Prothrombin Complex Concentrates (PCC); High-Dose 3-Factor Prothrombin Complex Concentrates (PCC); Lyophilized 3-Factor Prothrombin Complex Concentrates (PCC)
2) By Type: Low-Dose 4-Factor Prothrombin Complex Concentrates (PCC); High-Dose 4-Factor Prothrombin Complex Concentrates (PCC); Activated 4-Factor Prothrombin Complex Concentrates (PCC)
3) By Type: Recombinant Coagulation Factor Complexes; Plasma-Derived Coagulation Factor Complexes; Combination Therapy Products
Which Notable Trends Are Transforming The Prothrombin Complex Concentrate Market Outlook?
Key players in the prothrombin complex concentrate market are concentrating their efforts on the creation of novel formulations like lyophilized powder. This reformulation looks at improving stability, streamlining administration, and enhancing storage capabilities. Lyophilized powder, a freeze-dried formulation, extends shelf life and potency by removing water. It gives the advantage of improved storage conditions and quick reconstitution during emergencies. As an illustrative example, in July 2023, the US-based biotech enterprise, Octapharma USA Inc., secured FDA approval for Balfaxar, a four-factor prothrombin complex concentrate (4F-PCC) designed for immediate warfarin reversal during surgeries and invasive procedures. The approval was anchored on the LEX-209 trial, which demonstrated 94.6% hemostatic efficacy, thereby equating it with Kcentra. Such advancements reiterate the industry’s commitment to optimize coagulation treatments in order to improve patient results in critical care environments.
Which Firms Are Making The Biggest Impact In The Prothrombin Complex Concentrate Market?
Major companies operating in the prothrombin complex concentrate market are Pfizer Inc., Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, CSL Behring GmbH, Intas Pharmaceuticals Ltd, Baxter International Inc, Grifols S.A., Octapharma AG, Kedrion S.p.A, Haemonetics Corporation, Green Cross Corporation, Shanghai RAAS Blood Products Co. Ltd, Emergent BioSolutions, LFB Group, Hualan Biological Engineering Chongqing Co. Ltd., Sanquin Blood Supply Foundation, Bio Products Laboratory Ltd (BPL), Prothya Biosolutions B.V., China Biologic Products Holdings Inc.
Access The Complete Report Here:
Which Geographic Regions Are Creating Strong Demand In The Prothrombin Complex Concentrate Market?
North America was the largest region in the prothrombin complex concentrate market in 2024. The regions covered in the prothrombin complex concentrate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=23488&type=smp
Browse Through More Reports Similar to the Global Prothrombin Complex Concentrate Market 2025, By The Business Research Company
Gastrointestinal Bleeding Treatment Devices Global Market Report 2025
Bleeding Disorders Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report
Cyclic Heavy Menstrual Bleeding Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
